AI-generated summary
The authors reviewed 10 studies of photobiomodulation for medication-related osteonecrosis of the jaw, a bone complication linked to certain antiresorptive drugs. They report that photobiomodulation may reduce MRONJ incidence after tooth extraction and improve treatment outcomes, with no adverse effects reported. They note that more randomized, double-blind studies are needed to confirm these results.
- Studies included
- 10
- Who or what was studied
- Patients receiving bone antiresorptive agents who develop or are at risk of medication-related osteonecrosis of the jaw after tooth extraction
- Wavelengths
- 980 nm
- Limits stated in the abstract
- The abstract states that further randomized, double-blind studies are needed, and the included evidence came from cohort and non-randomized studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Wound healing, Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.